⌘K

Login Start Free

Home/Filings/4/0001062993-25-001089

4//SEC Filing

Agarwal Arjun 4

Accession 0001062993-25-001089

CIK 0000907654other

View on SEC.gov Company Profile

Filed

Jan 23, 7:00 PM ET

Accepted

Jan 24, 4:44 PM ET

Size

5.5 KB

Accession

0001062993-25-001089

Insider Transaction Report

Form 4

Period: 2025-01-22

Oruka Therapeutics, Inc.ORKA

SVP, Finance

Transactions

Award
Employee Stock Option (right to buy)
2025-01-22+120,000→ 120,000 total
Exercise: $12.50Exp: 2035-01-21→ Common Stock (120,000 underlying)

Footnotes (1)

[F1]The option vests as to 1/48 of the underlying shares monthly from January 1, 2025.

Documents

1 file

4
form4.xmlPrimary
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Issuer

Oruka Therapeutics, Inc.

CIK 0000907654

Entity typeother

Related Parties

1

filerCIK 0002033974

Filing Metadata

Form type: 4
Filed: Jan 23, 7:00 PM ET
Accepted: Jan 24, 4:44 PM ET
Size: 5.5 KB

View on SEC.gov